However, in newly diagnosed GBM patients (N = 15; n = 30) the mean p-STAT-3 level was 8.4 ± 8.8%, which was not significantly different from that of healthy donors (P = 0.3), although there was a trend toward increased levels in the GBM group. Here, STAT3 is linked to glioblastoma.